Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Inhaler add-on device aims to improve patient technique

Manufacturer Clement Clarke International has launched an inhaler add-on device that aims to coach patients on correct inhaler technique.

The Flo-Tone Trainer can be attached to the mouthpiece of an inhaler, and will give an audible signal to indicate when the patient is using the inhaler at the correct inspiratory flow rate.

The product is intended to help reduce the problem of patients using the device improperly – decreasing the need for reliever medications, hospitalisations and asthma-related deaths. "Many patients inhale too quickly, with the result that much of the medication impacts in the throat, instead of reaching the lungs," the company said.

Clement Clarke managing director Mark Sanders reported that the company had received "outstanding" feedback on the Flo-Tone device.

"We anticipate this simple, low-cost solution can bring substantial health gain and reduced healthcare costs," he said.

For more information, call 01279 414969 or visit flo-tone.com

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD015867

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel